65
Growth Score in past quarter
pts
Heat Score 65 in past quarter
13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
522435
ImmunoRestoration is a commercialize groundbreaking Company.
- Eileen Daniel: Chief Operating Officer
- James Conklin: Chief Medical Officer
About the Company
ImmunoRestoration, Inc. was formed in 2016 to commercialize groundbreaking immunotherapeutic cancer vaccine research begun in 2004 at the University of Pennsylvania. The decision to pursue this opportunity was made after carefully evaluating data associated with pre-clinical research and studies involving more than 100 patients. Late in 2017, the
company acquired the global exclusive rights to bring this technology to market and is now poised to help usher in a new era of precision, patient-centric cancer treatment.